ES2032393T3 - Metodo para producir un preparado acuoso. - Google Patents

Metodo para producir un preparado acuoso.

Info

Publication number
ES2032393T3
ES2032393T3 ES198787102102T ES87102102T ES2032393T3 ES 2032393 T3 ES2032393 T3 ES 2032393T3 ES 198787102102 T ES198787102102 T ES 198787102102T ES 87102102 T ES87102102 T ES 87102102T ES 2032393 T3 ES2032393 T3 ES 2032393T3
Authority
ES
Spain
Prior art keywords
cyclodextrin
aqueous preparation
produce
beta
dimethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787102102T
Other languages
English (en)
Inventor
Yujiro Yamamoto
Hideo Terayama
Yasushi Morita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2032393T3 publication Critical patent/ES2032393T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

ESTA INVENCION SE REFIERE A UNA PREPARACION ACUOSA QUE CONTIENE UN COMPUESTO REPRESENTADO POR LA FORA, Y POR LO MENOS UNA CICLODEXTRINA ELEGIDA DE (ALFA)-CICLODEXTRINA Y DIMETIL-(BETA)-CICLODEXTRINA; Y UN METODO PARA PREPARARLA. DE ACUERDO CON LA PREPARACION ACUOSA DE ESTA INVENCION, LA COEXISTENCIA CON UN MEDICAMENTO ELEGIDO DE CICLODEXTRINA Y DIMETIL-(BETA)-CICLODEXTRINA POR LO MENOS PERMITE MEJORAR LA SOLUBILIDAD EN AGUA DEL COMPUESTO (A), ESENCIAL EN ESTA INVENCION, EN UNA CONCENTRACION TAL QUE HACE UN EFECTO CURATIVO ESPERADO APROVECHABLE, E IMPARTIRLE LA ESTABILIDAD DESEADA. COMO CONSECUENCIA, EL CITADO COMPUESTO (A) SE PUEDE UTILIZAR COMO MEDICAMENTO EN UNA PREPARACION ACUOSA QUE TIENE ACCION ANTIALERGICA.
ES198787102102T 1986-02-17 1987-02-14 Metodo para producir un preparado acuoso. Expired - Lifetime ES2032393T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61032265A JPH0637388B2 (ja) 1986-02-17 1986-02-17 水性液剤

Publications (1)

Publication Number Publication Date
ES2032393T3 true ES2032393T3 (es) 1993-02-16

Family

ID=12354174

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787102102T Expired - Lifetime ES2032393T3 (es) 1986-02-17 1987-02-14 Metodo para producir un preparado acuoso.

Country Status (7)

Country Link
US (1) US4822823A (es)
EP (1) EP0233615B1 (es)
JP (1) JPH0637388B2 (es)
CA (1) CA1281650C (es)
DE (1) DE3776920D1 (es)
ES (1) ES2032393T3 (es)
HU (1) HU198839B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201685B (en) * 1987-04-23 1990-12-28 Chinoin Gyogyszer Es Vegyeszet For producing pharmaceutical compositions for inhalation and compositions for scenting air containing volatile active component in cyclodextrine inclusion, and air-scenting composition
JPS6416728A (en) * 1987-07-07 1989-01-20 Santen Pharmaceutical Co Ltd Aqueous preparation
NL9001681A (nl) * 1990-07-24 1992-02-17 Rijksuniversiteit Transmucosale geneesmiddelpreparaten en transmucosale toediening.
IT1265647B1 (it) * 1992-11-18 1996-11-22 Farmin Srl Composizione farmaceutiche topiche per le allergie respiratorie
US5264619B1 (en) * 1993-01-15 1996-05-14 Cosmos Pharm Corp Anti-androgenic cyclo and bicyclo alkenes
JP3889481B2 (ja) 1996-08-16 2007-03-07 株式会社カネカ 医薬組成物
EP1006969A1 (en) * 1996-09-27 2000-06-14 Nastech Pharmaceutical Co. Intranasal formulations for promoting sleep and method of using the same
DE10035513A1 (de) 2000-07-21 2002-01-31 Beiersdorf Ag Wirkstoffkombinationen bzw. Addukte aus Cyclodextrinen und mindestens einem Chinon und/oder mindestens einem Hydrochinon und Verwendung solcher Wirkstoffkombinationen in kosmetischen Zubereitungen
DE102004024452A1 (de) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation von Betaagonisten
JP2006008568A (ja) * 2004-06-24 2006-01-12 Cyclochem:Kk ＩｇＥ抗体抑制剤および食品
WO2007059507A2 (en) * 2005-11-15 2007-05-24 Baxter International, Inc. Compositions comprising lipoxygenase inhibitors and cyclodextrin
JP2007176797A (ja) * 2005-12-26 2007-07-12 Toyo Hakko:Kk 抗アレルギー性組成物並びにこれを含有する飲食物及び飲食物用添加剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4393075A (en) * 1980-04-14 1983-07-12 Takeda Chemical Industries, Ltd. Quinone compounds and their use in suppressing the production of SRS-A in mammals
JPS57109739A (en) * 1980-12-27 1982-07-08 Takeda Chem Ind Ltd Quinone compound and its preparation
HU181703B (en) * 1980-05-09 1983-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing aqueus solutuins of water insoluble or hardly soluble vitamines, steroides, localanesthetics, prostanoides and non-steroid and antiphlogistic agents
JPS5947202A (ja) * 1982-09-10 1984-03-16 Zeria Shinyaku Kogyo Kk 補酵素Ｑ↓１↓０のメチル化−β−シクロデキストリン包接体及びその製造方法
JPH11475A (ja) * 1997-06-11 1999-01-06 Yoshihiko Akamine 三次元の立体落ち系パズルのテレビゲーム

Also Published As

Publication number Publication date
EP0233615A3 (en) 1987-10-14
EP0233615B1 (en) 1992-03-04
US4822823A (en) 1989-04-18
DE3776920D1 (de) 1992-04-09
EP0233615A2 (en) 1987-08-26
JPH0637388B2 (ja) 1994-05-18
CA1281650C (en) 1991-03-19
HU198839B (en) 1989-12-28
HUT47216A (en) 1989-02-28
JPS62190121A (ja) 1987-08-20

Similar Documents

Publication Publication Date Title
ES2032393T3 (es) Metodo para producir un preparado acuoso.
ES2054678T3 (es) Conjugados estrella.
MX9206817A (es) Nuevos azoheterociclilmetil-cromanos, procedimiento para su obtencion y medicamento que los contiene.
ES2054649T3 (es) 2-aminotetralinas basicas substituidas.
ES2077530B1 (es) Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales.
AR010385A1 (es) Compuesto derivado de propiofenona, proceso para su preparacion, composicion farmaceutica que lo contiene y uso de dicho compuesto.
ES2079176T3 (es) Agente de contraste para ecografia.
BRPI0112962B8 (pt) composições farmacêuticas compreendendo ácido hialurônico, ácido glicirretínico e polivinilpirrolidona, e uso desses compostos na preparação de medicamentos
ES2009153A6 (es) Un metodo mejorado para preparar un compuesto de aluminio con una actividad antitranspirante potenciada.
ES2098140T3 (es) Liosferas que contienen gonadotropina.
ES2037385T3 (es) Un procedimiento de manufactura de una preparacion farmaceutica para administracion local.
ES2103570T3 (es) Desinfeccion de soluciones acuosas.
SV1999000048A (es) Uso de dihidropiriminas como medicamento y nuevas sustancias ref. lea 32 791-sv
ES2084168T3 (es) Composiciones antimalaricas.
ES2176186T3 (es) Derivados de 2-imidazolina-5-ona y 2-imidazolina-5-tionas con propiedades fungicidas.
AR012504A1 (es) Utilizacion de derivados de tetrahidropiridina, para la preparacion de medicamentos para el tratamiento de las enfermedades que provocan unadesmielinizacion.
ES2109412T3 (es) (-)-cimaterol en esencia opticamente puro y sus sales por adicion de acidos, asi como su empleo como medicamento o favorecedor del rendimiento.
ES2096973T3 (es) Fosfazenos que contienen radicales organicos de silicio, proceso para su preparacion, y su empleo.
ES2172558T3 (es) Lubricante compatible con radiaciones para dispositivos medicos.
MX9300558A (es) Nueva sulfonilurea, procedimiento para su preparacion y formulado farmaceutico que la contiene.
ES2075454T3 (es) Forma cristalina pura de rifapentina.
ES2145114T3 (es) Combinacion de atovacuona con proguanil para el tratamiento de infecciones protozoarias.
GT197432532A (es) Procedimiento para preparar 3- fluocefalosporinas.
ES2062997T3 (es) Vinilcefalosporinas sustituidas, procedimiento para su fabricacion y su uso como medicamento.
ES2072332T3 (es) Derivados de la dibenzo(1,5)dioxocin-5-ona, su uso en medicamentos y procedimiento para su fabricacion.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 233615

Country of ref document: ES